Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic)

NCT02267304 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER_GOV

Sponsor class

Conditions

Healthy

Interventions

DRUG: 50 mL of sodium chloride (0,9%)
DRUG: Morphine 0,05mg/kg
DRUG: Naloxone 10mg

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France